NDC00701-0620-08: HALOPERIDOL ORAL SOLUTION.
The HALOPERIDOL ORAL SOLUTION is a the manufacturer industrial component. Key specifications include administration: ORAL, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 237 TO 240 ML. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-259-2566, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | UNFLAVORED; COLORLESS; STORE AT ROOM TEMPERATURE OF 59 TO 86 F. (15 TO 30 C.); FEATGACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS HALOPERIDOL PER MILLILITER |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 237 TO 240 ML |
| NSN | 6505-01-259-2566 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 237 TO 240 ML |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | UNFLAVORED; COLORLESS; STORE AT ROOM TEMPERATURE OF 59 TO 86 F. (15 TO 30 C.); FEATGACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS HALOPERIDOL PER MILLILITER |